Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels nut negative I-131 whole body scan

Clinical Radiology

Volumn 58, Issue 10, 2003, Pages 787-790

  Wu, H S ^a   Liu, F Y ^b   Huang, W S ^c   Liu, Y C ^c   Chang, C T ^d   Kao, C H ^d  

^a SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Papillary thyroid carcinoma; Single photon emission computed tomography; Thechnetium 99m tetrofosmin

Indexed keywords

IODINE 131; TETROFOSMIN TC 99M; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TUMOR BIOPSY; WHOLE BODY SCINTISCANNING;

EID: 0141886010     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9260(03)00256-3     Document Type: Article

References (19)

1. Collins SL. Thyroid cancer: controversies and etiopathogenesis, In: Falk SA, ed. Thyroid disease. Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy, 2nd edn Lippincott-Raven: Philadelphia, PA, 1997, 495-564.
2. Mazzaferri EL. Diagnosis and management of papillary and follicular thyroid carcinomas, In: Surks MI, ed. Thyroid Diseases. Blackwell Science: Philadelphia, PA, 1999, 67-80.
3. Lubin E, Mechlis-Frisch S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med, 1994;35:257-262.
4. Filesi M, Signore A, Ventroni G, et al. Role of initial iodine-131 whole body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med, 1998;39:1542-1546.
5. Galloway RJ, Smallridge RC. Imaging in thyroid cancer. Endocrinol Metab Clin N Am, 1996;25:93-113.
6. Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab, 1985;60:376-380.
7. 131I whole-body scan. J Nucl Med, 1999;40: 986-992.
8. Feine U, Lietzenmayer R, Hanke JP, et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med, 1996;37:1468-1472.
9. Grunwald F, Menzel C, Bender H, et al. Comparison of 18FDG-PET with 131-iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid, 1997;7:327-335.
10. 131I in patients with metastatic thyroid carcinoma. Nucl Med Commun, 1997;18:3-9.
11. Piwnica-Worms D, Holman LB. Noncardiac application of hexakis (alkyl-isonitrile) technetium-99m complexes. J Nucl Med, 1990;31: 1166-1167.
12. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyiso-butylisonitrile) technetium I in cultured mouse fibroblast. J Nucl Med, 1990;31:1646-1653.
13. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis (bis (2-ethoxyethyl) phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med, 1993; 34:30-38.
14. Kanmaz B, Erdil TY, Yardi OF, et al. The role of 99Tcm-tetrofosmin in the evaluation of thyroid nodules. Nucl Med Commun, 2000;21: 333-339.
15. Klain M, Maurea S, Cuocolo A, et al. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans. Eur J Nucl Med, 1996;23:1568-1574.
16. Gallowitsch HJ, Kresnik E, Mikosch P, et al. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma-preliminary results. Nuklearmedizin, 1996;35:230-235.
17. Haugen BR, Lin EC. Isotope imaging for metastatic thyroid cancer. Endocrinol Metab Clin N Am, 2001;30:469-492.
18. Lind P, Gallowitsch HJ. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Acta Med Austriaca, 1996;23:69-75.
19. Lind P, Gallowitsch HJ, Langsteger W, et al. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med, 1997;38:348-352.